TransCode Therapeutics
RNAZ----
全部股东
股东类型
- 私营企业85.26%
- 公众及其他12.20%
- 个人与内部人士2.03%
- 机构投资者0.52%
主要股东
| 股东 | |||||
|---|---|---|---|---|---|
DEFJ, LLC | 83.48% | 1,413.45 万 | 75.25% | +1,405.12 万 | |
Unleash Immuno Oncolytics, Inc. | 1.77% | 30.00 万 | -- | +30.00 万 | |
Elena Braci | 1.10% | 18.62 万 | -- | +18.62 万 | |
Daniel Katzman | 0.92% | 15.56 万 | -- | +15.56 万 | |
Sabby Management, LLC | 0.25% | 4.16 万 | 4.29% | +0 | |
Yorkville Advisors Global LP | 0.12% | 1.96 万 | -- | +1.96 万 | |
Geode Capital Management, LLC | 0.08% | 1.27 万 | 1.31% | +0 | |
Vanguard Capital Management, LLC | 0.06% | 9,527.00 | 0.98% | +0 | |
UBS Asset Management AG | 0.02% | 2,888.00 | 0.89% | -5,407.00 | |
Thomas Tracy | <0.01% | 1,250.00 | 0.13% | +0 | |
Strategic Advisers LLC | <0.01% | 706.00 | -- | +706.00 | |
Tower Research Capital Europe Limited | <0.01% | 677.00 | 0.02% | +449.00 | |
The Goldman Sachs Group, Inc. | <0.01% | 82.00 | <0.01% | +0 | |
Wells Fargo & Company | <0.01% | 55.00 | <0.01% | +0 | |
SBI Holdings, Inc. | <0.01% | 12.00 | <0.01% | +0 | |
Thomas FitzgeraldFormer CFO, Secretary, President, VP of Administration & Director | <0.01% | 3.00 | <0.01% | +1.00 | |
Philippe CalaisCEO & Executive Chairman of the Board | <0.01% | 2.00 | <0.01% | +1.00 | |
Erik MantingIndependent Director | 0.00% | 0.00 | 0.00% | +0 | |
RBC Dominion Securities Inc. | 0.00% | 0.00 | <0.01% | -8.00 | |
Magda MarquetIndependent Director | 0.00% | 0.00 | 0.00% | +0 |